Autopsy report · NCT03551509

LifeNet: Extracellular Matrix Graft in Rotator Cuff Repair

“Sponsor terminated early”

The sponsor’s own words in the registry.

Life of this trial

• Registered 2 months before it started.
• Ran for about 6 years before it stopped.
• 9 participants enrolled.
• Results were posted on the registry 1 year after it ended.

Vital statistics

Status

Terminated

Phase

Phase 4

Sponsor

Gregory Gilot

Sponsor type

University, hospital or other

Conditions

Rotator Cuff Tear

Interventions

ArthroFLEX ECM scaffold graft; Control; Alternative Treatment Group

Participants

9

Sites

1

Countries

United States

Trials that died the same way

• Use of INTEGRA™ Flowable Wound Matrix to Manage Diabetic Foot Ulcers
  “Sponsor Terminated” (87% match in meaning)
• Evaluation of Cranioplasty Using Native Bone Autograft Versus Synthetic Bone Allograft
  “Sponsor termination” (84% match in meaning)
• A Clinical Trial of a Hemp-Derived Cannabidiol Product for Anxiety
  “Terminated by sponsor” (82% match in meaning)
• Phase 1 Trial of RP-3467 Alone and in Combination With Olaparib in Participants With Advanced Solid Tumors
  “Sponsor decided to terminate study early” (81% match in meaning)
• Pomalidomide With Melphalan and Dexamethasone for Untreated Systemic AL Amyloidosis
  “Sponsor requested termination” (81% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.